Transcriptomic Assay of CD8+ T Cells in Treatment-Naïve HIV, HCV-Mono-Infected and HIV/HCV-Co-Infected Chinese

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Zhao, Jin ^a,b   Yi, Lina ^a   Lu, Jing ^a   Yang, Zheng Rong ^b   Chen, Ying ^a   Zheng, Chenli ^b   Huang, Dan ^b,c   Li, Yu Feng ^c   Chen, Lin ^b   Cheng, Jinquan ^b   Kung, Hsiang fu ^a   He, Ming Liang ^a  

^a Prince of Wales Hospital   (Hong Kong)

^b SHENZHEN CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c XIHUA UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

ADULT; ARTICLE; CD8+ T LYMPHOCYTE; CHINESE; CONTROLLED STUDY; DRUG EXPOSURE; GENE EXPRESSION PROFILING; GENE NUMBER; GENETIC ASSOCIATION; GENETIC SIMILARITY; HEPATITIS C; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MIXED INFECTION; REAL TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; TRANSCRIPTOMICS;

HEPATITIS C VIRUS;

EID: 84866413845     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045200     Document Type: Article

References (46)

1. Tan Y, Wei QH, Chen LJ, Chan PC, Lai WS, et al. (2008) Molecular epidemiology of HCV monoinfection and HIV/HCV coinfection in injection drug users in Liuzhou, Southern China. PLoS One 3: e3608.
2. Alter MJ, (2006) Epidemiology of viral hepatitis and HIV co-infection. J Hepatol 44: S6-9.
3. England K, Thorne C, Newell ML, (2006) Vertically acquired paediatric coinfection with HIV and hepatitis C virus. Lancet Infect Dis 6: 83-90.
4. Loko MA, Bani-Sadr F, Winnock M, Lacombe K, Carrieri P, et al. (2011) Impact of HAART exposure and associated lipodystrophy on advanced liver fibrosis in HIV/HCV-coinfected patients. J Viral Hepat 18: e307-314.
5. Daar ES, Lynn H, Donfield S, Gomperts E, Hilgartner MW, et al. (2001) Relation between HIV-1 and hepatitis C viral load in patients with hemophilia. J Acquir Immune Defic Syndr 26: 466-472.
6. McGovern BH (2007) Hepatitis C in the HIV-infected patient. J Acquir Immune Defic Syndr 45 (Suppl 2) (): S47-56; discussion S66-47.
7. Merchante N, Giron-Gonzalez JA, Gonzalez-Serrano M, Torre-Cisneros J, Garcia-Garcia JA, et al. (2006) Survival and prognostic factors of HIV-infected patients with HCV-related end-stage liver disease. AIDS 20: 49-57.
8. Lee S, Watson MW, Clark B, Flexman JP, Cheng W, et al. (2006) Hepatitis C virus genotype and HIV coinfection affect cytokine mRNA levels in unstimulated PBMC but do not shift the T1/T2 balance. Immunol Cell Biol 84: 390-395.
9. Mauboussin JM, Mahamat A, Peyriere H, Rouanet I, Fabbro-Peray P, et al. (2004) Low plasma levels of dehydroepiandrosterone sulphate in HIV-positive patients coinfected with hepatitis C virus. HIV Med 5: 151-157.
10. de Mendoza C, Sanchez-Conde M, Timmermans E, Buitelaar M, de Baar MP, et al. (2005) Mitochondrial DNA depletion in HIV-infected patients is more pronounced with chronic hepatitis C and enhanced following treatment with pegylated interferon plus ribavirin. Antivir Ther 10: 557-561.
11. de Mendoza C, Martin-Carbonero L, Barreiro P, de Baar M, Zahonero N, et al. (2007) Mitochondrial DNA depletion in HIV-infected patients with chronic hepatitis C and effect of pegylated interferon plus ribavirin therapy. AIDS 21: 583-588.
12. Wright TL, Hollander H, Pu X, Held MJ, Lipson P, et al. (1994) Hepatitis C in HIV-infected patients with and without AIDS: prevalence and relationship to patient survival. Hepatology 20: 1152-1155.
13. Morsica G, Bagaglio S, Ghezzi S, Lodrini C, Vicenzi E, et al. (2007) Hepatitis C virus (HCV) coinfection in a cohort of HIV positive long-term non-progressors: possible protective effect of infecting HCV genotype on HIV disease progression. J Clin Virol 39: 82-86.
14. d'Arminio Monforte A, Cozzi-Lepri A, Castagna A, Antinori A, De Luca A, et al. (2009) Risk of developing specific AIDS-defining illnesses in patients coinfected with HIV and hepatitis C virus with or without liver cirrhosis. Clin Infect Dis 49: 612-622.
15. Chen TY, Ding EL, Seage Iii GR, Kim AY, (2009) Meta-analysis: increased mortality associated with hepatitis C in HIV-infected persons is unrelated to HIV disease progression. Clin Infect Dis 49: 1605-1615.
16. Piroth L, Duong M, Quantin C, Abrahamowicz M, Michardiere R, et al. (1998) Does hepatitis C virus co-infection accelerate clinical and immunological evolution of HIV-infected patients? AIDS 12: 381-388.
17. Labarga P, Soriano V, Vispo ME, Pinilla J, Martin-Carbonero L, et al. (2007) Hepatotoxicity of antiretroviral drugs is reduced after successful treatment of chronic hepatitis C in HIV-infected patients. J Infect Dis 196: 670-676.
18. Koziel MJ, Peters MG, (2007) Viral hepatitis in HIV infection. N Engl J Med 356: 1445-1454.
19. Sulkowski MS, Thomas DL, (2003) Hepatitis C in the HIV-infected patient. Clin Liver Dis 7: 179-194.
20. Zylberberg H, Benhamou Y, Lagneaux JL, Landau A, Chaix ML, et al. (2000) Safety and efficacy of interferon-ribavirin combination therapy in HCV-HIV coinfected subjects: an early report. Gut 47: 694-697.
21. Lafeuillade A, Hittinger G, Chadapaud S, (2001) Increased mitochondrial toxicity with ribavirin in HIV/HCV coinfection. Lancet 357: 280-281.
22. Klenerman P, Kim A, (2007) HCV-HIV coinfection: simple messages from a complex disease. PLoS Med 4: e240.
23. Hyrcza MD, Kovacs C, Loutfy M, Halpenny R, Heisler L, et al. (2007) Distinct transcriptional profiles in ex vivo CD4+ and CD8+ T cells are established early in human immunodeficiency virus type 1 infection and are characterized by a chronic interferon response as well as extensive transcriptional changes in CD8+ T cells. J Virol 81: 3477-3486.
24. Chen L, Borozan I, Feld J, Sun J, Tannis LL, et al. (2005) Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection. Gastroenterology 128: 1437-1444.
25. Liu FT, Giustiniani J, Farren T, Jia L, Bensussan A, et al. (2010) CD160 signaling mediates PI3K-dependent survival and growth signals in chronic lymphocytic leukemia. Blood 115: 3079-3088.
26. Gong D, Ferrell JE Jr, (2010) The roles of cyclin A2, B1, and B2 in early and late mitotic events. Mol Biol Cell 21: 3149-3161.
27. Kassu A, D'Souza M, O'Connor BP, Kelly-McKnight E, Akkina R, et al. (2009) Decreased 4-1BB expression on HIV-specific CD4+ T cells is associated with sustained viral replication and reduced IL-2 production. Clin Immunol 132: 234-245.
28. Raemaekers T, Ribbeck K, Beaudouin J, Annaert W, Van Camp M, et al. (2003) NuSAP, a novel microtubule-associated protein involved in mitotic spindle organization. J Cell Biol 162: 1017-1029.
29. Shimura M, Tokunaga K, Konishi M, Sato Y, Kobayashi C, et al. (2005) Premature sister chromatid separation in HIV-1-infected peripheral blood lymphocytes. AIDS 19: 1434-1438.
30. Shimura M, Toyoda Y, Iijima K, Kinomoto M, Tokunaga K, et al. (2011) Epigenetic displacement of HP1 from heterochromatin by HIV-1 Vpr causes premature sister chromatid separation. J Cell Biol 194: 721-735.
31. Shields PL, Morland CM, Salmon M, Qin S, Hubscher SG, et al. (1999) Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver. J Immunol 163: 6236-6243.
32. Missale G, Bertoni R, Lamonaca V, Valli A, Massari M, et al. (1996) Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. J Clin Invest 98: 706-714.
33. Barber DL, Wherry EJ, Masopust D, Zhu B, Allison JP, et al. (2006) Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439: 682-687.
34. Kovacs A, Al-Harthi L, Christensen S, Mack W, Cohen M, et al. (2008) CD8(+) T cell activation in women coinfected with human immunodeficiency virus type 1 and hepatitis C virus. J Infect Dis 197: 1402-1407.
35. Racanelli V, Leone P, Grakoui A, (2011) A spatial view of the CD8+ T-cell response: the case of HCV. Rev Med Virol 21: 347-357.
36. Walters KA, Smith MW, Pal S, Thompson JC, Thomas MJ, et al. (2006) Identification of a specific gene expression pattern associated with HCV-induced pathogenesis in HCV- and HCV/HIV-infected individuals. Virology 350: 453-464.
37. Hisada M, Chatterjee N, Kalaylioglu Z, Battjes RJ, Goedert JJ, (2005) Hepatitis C virus load and survival among injection drug users in the United States. Hepatology 42: 1446-1452.
38. Iyasere C, Tilton JC, Johnson AJ, Younes S, Yassine-Diab B, et al. (2003) Diminished proliferation of human immunodeficiency virus-specific CD4+ T cells is associated with diminished interleukin-2 (IL-2) production and is recovered by exogenous IL-2. J Virol 77: 10900-10909.
39. Zimmerli SC, Harari A, Cellerai C, Vallelian F, Bart PA, et al. (2005) HIV-1-specific IFN-gamma/IL-2-secreting CD8 T cells support CD4-independent proliferation of HIV-1-specific CD8 T cells. Proc Natl Acad Sci U S A 102: 7239-7244.
40. Ciuffreda D, Comte D, Cavassini M, Giostra E, Buhler L, et al. (2008) Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replication. Eur J Immunol 38: 2665-2677.
41. Lauer GM, Nguyen TN, Day CL, Robbins GK, Flynn T, et al. (2002) Human immunodeficiency virus type 1-hepatitis C virus coinfection: intraindividual comparison of cellular immune responses against two persistent viruses. J Virol 76: 2817-2826.
42. Kendziorski C, Irizarry RA, Chen KS, Haag JD, Gould MN, (2005) On the utility of pooling biological samples in microarray experiments. Proc Natl Acad Sci U S A 102: 4252-4257.
43. Peng X, Wood CL, Blalock EM, Chen KC, Landfield PW, et al. (2003) Statistical implications of pooling RNA samples for microarray experiments. BMC Bioinformatics 4: 26.
44. Lyons PA, Koukoulaki M, Hatton A, Doggett K, Woffendin HB, et al. (2007) Microarray analysis of human leucocyte subsets: the advantages of positive selection and rapid purification. BMC Genomics 8: 64.
45. Gutierrez NC, Lopez-Perez R, Hernandez JM, Isidro I, Gonzalez B, et al. (2005) Gene expression profile reveals deregulation of genes with relevant functions in the different subclasses of acute myeloid leukemia. Leukemia 19: 402-409.
46. Lu J, Yi L, Zhao J, Yu J, Chen Y, et al. (2012) Enterovirus 71 disrupts interferon signaling by reducing the level of interferon receptor 1. J Virol 86: 3767-3776.